MCID/low disease activity state workshop: Summary, recommendations, and research agenda

George Wells*, Jennifer Anderson, Maarten Boers, David Felson, Turid Heiberg, Sarah Hewlett, Kent Johnson, John Kirwan, Marissa Lassere, Vivian Robinson, Beverley Shea, Lee Simon, Vibeke Strand, Piet Van Riel, Peter Tugwell

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)

33 Citations (Scopus)

Abstract

The OMERACT 6 Minimal Clinically Important Difference/Low Disease Activity Workshop was organized with the aim of meeting the many challenges that exist in determining a low disease activity in rheumatoid arthritis (RA). This article presents an overview of that workshop, including results of the voting, a summary of associated discussions, recommendations, and a proposed research agenda.

Original languageEnglish
Pages (from-to)1115-1118
Number of pages4
JournalJournal of Rheumatology
Volume30
Issue number5
Publication statusPublished - 1 May 2003

Keywords

  • Disease activity
  • Outcome and process assessment
  • Rheumatoid arthritis

Fingerprint Dive into the research topics of 'MCID/low disease activity state workshop: Summary, recommendations, and research agenda'. Together they form a unique fingerprint.

Cite this